{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:24:35Z","timestamp":1789435475651,"version":"build-2803163510"},"reference-count":17,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004600","name":"Kyungpook National University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004600","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04qn0xg47","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a leading cause of cancer-related mortality worldwide. Lung adenocarcinoma (AD) and lung squamous cell carcinoma (SCC) represent the two major histological subtypes with distinct molecular characteristics. POU domain class 6 transcription factor 1 (POU6F1) is involved in gene regulation and cellular differentiation, but its clinical significance in NSCLC remains unclear. This study investigated the clinicopathologic and prognostic significance of POU6F1 expression in NSCLC. POU6F1 mRNA expression was analyzed in tumor tissues obtained from 153 patients with NSCLC using quantitative real-time polymerase chain reaction. The associations between POU6F1 expression and clinicopathological characteristics were evaluated, and survival analysis was performed to determine its prognostic value. In addition, publicly available datasets from The Cancer Genome Atlas (TCGA) were analyzed to validate the clinical significance of POU6F1 expression. High POU6F1 expression was observed in 48 patients (31.4%), whereas 105 patients (68.6%) showed low expression. High POU6F1 expression was significantly associated with younger age (p = 0.027), female sex (p = 0.041), non-smoking status (p = 0.002), adenocarcinoma histology (p = 0.021), and the presence of EGFR mutations (p = 0.038). Survival analysis demonstrated that high POU6F1 expression was associated with improved overall survival in patients with NSCLC (p = 0.015). When stratified by histological subtype, higher POU6F1 expression was associated with better survival outcomes in AD but not in SCC. Analysis of TCGA datasets confirmed that elevated POU6F1 expression was significantly associated with favorable survival in AD, whereas no significant prognostic value was observed in SCC. POU6F1 expression is significantly associated with clinicopathological characteristics and improved survival in patients with lung AD. Multivariate Cox regression analysis further confirmed that POU6F1 expression was an independent prognostic factor for overall survival. These findings suggest that POU6F1 may serve as a potential prognostic biomarker based on mRNA expression in NSCLC, particularly in AD. Further studies are warranted to validate these findings at the protein level and to elucidate the underlying biological mechanisms.<\/jats:p>","DOI":"10.3390\/cimb48050456","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:09:33Z","timestamp":1777388973000},"page":"456","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["POU6F1 Expression Predicts Favorable Prognosis in Lung Adenocarcinoma: Validation Using Patient Cohort and TCGA Data"],"prefix":"10.3390","volume":"48","author":[{"given":"Mincheol","family":"Chae","sequence":"first","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu 42403, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-0720","authenticated-orcid":false,"given":"Jae-Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Keimyung University School of Medicine, Daegu 42403, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyowon","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Keimyung University School of Medicine, Daegu 42403, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yoon","family":"Keum","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu 42403, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-4745","authenticated-orcid":false,"given":"Deok Heon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung Cancer: Current Therapies and New Targeted Treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The Biology and Management of Non-Small Cell Lung Cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vishnoi, K., Viswakarma, N., Rana, A., and Rana, B. (2020). Transcription Factors in Cancer Development and Therapy. Cancers, 12.","DOI":"10.3390\/cancers12082296"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marqu\u00e9s, M., Sorolla, M.A., Urdanibia, I., Parisi, E., Hidalgo, I., Morales, S., Salud, A., and Sorolla, A. (2022). Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?. Cancers, 14.","DOI":"10.3390\/cancers14051101"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/mcne.2000.0957","article-title":"The POU Gene Brn-5 Is Induced by Neuregulin and Is Restricted to Myelinating Schwann Cells","volume":"17","author":"Wu","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23390","DOI":"10.1016\/S0021-9258(19)49475-1","article-title":"Brn-5 Is a Divergent POU Domain Factor Highly Expressed in Layer IV of the Neocortex","volume":"268","author":"Andersen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1749-0774.2009.00074.x","article-title":"POU6F1 Is the Transcription Factor That Might Be Involved in Cell Proliferation of Clear Cell Adenocarcinoma of the Ovary","volume":"22","author":"Yoshioka","year":"2009","journal-title":"Hum. Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/IGC.0b013e3181c97ae0","article-title":"Transcription Factor POU6F1 Is Important for Proliferation of Clear Cell Adenocarcinoma of the Ovary and Is a Potential New Molecular Target","volume":"20","author":"Suzuki","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41419-022-04857-y","article-title":"POU6F1 Cooperates with RORA to Suppress the Proliferation of Lung Adenocarcinoma by Downregulating HIF1A Signaling Pathway","volume":"13","author":"Xiao","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kim, N., Cha, H., Lee, J.-C., Lee, J.-H., and Kim, T.-Y. (2026). CHEK1 Expression Correlates with Tumor Progression in Lung Adenocarcinoma but Not in Squamous Cell Carcinoma. Medicina, 62.","DOI":"10.3390\/medicina62020335"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10565-024-09843-y","article-title":"POU6F1 Promotes Ferroptosis by Increasing lncRNA-CASC2 Transcription to Regulate SOCS2\/SLC7A11 Signaling in Gastric Cancer","volume":"40","author":"Wang","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103257","DOI":"10.1016\/j.tice.2025.103257","article-title":"POU6F1 Inhibits Cervical Cancer Progression by Activating MAOB to Block the ERK1\/2 Pathway","volume":"99","author":"Chen","year":"2026","journal-title":"Tissue Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal Growth Factor Receptor Mutations in Lung Cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2014). Comprehensive Molecular Profiling of Lung Adenocarcinoma. Nature, 511, 543\u2013550. Erratum in Nature 2014, 514, 262.","DOI":"10.1038\/nature13385"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/456\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:39:25Z","timestamp":1778837965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cimb48050456"],"URL":"https:\/\/doi.org\/10.3390\/cimb48050456","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}